Download duplicate Questions of 190-956 exam that showed up in actual test today

There are many audits of killexams.com present on the web that will cause you to feel that you have tracked down the specific wellspring of legitimate IBM Lotus Notes Domino 8.5 System Administration Update Question Bank. Practically every one of the up-and-comers finishes their tests thinking carefully that contains actual test questions and replies. Retaining and rehearsing 190-956 exam dumps is adequate to pass with good grades.

Exam Code: 190-956 Practice exam 2022 by Killexams.com team
IBM Lotus Notes Domino 8.5 System Administration Update
Lotus Administration mission
Killexams : Lotus Administration mission - BingNews https://killexams.com/pass4sure/exam-detail/190-956 Search results Killexams : Lotus Administration mission - BingNews https://killexams.com/pass4sure/exam-detail/190-956 https://killexams.com/exam_list/Lotus Killexams : Expert: How will China's Zhurong rover survive Mars' coldest season?

Selfie of China's Zhurong rover (L) and the landing platform. /CNSA

Selfie of China's Zhurong rover (L) and the landing platform. /CNSA

The northern hemisphere of Mars, where China's Zhurong, the rover of China's first interplanetary probe mission Tianwen-1, ushered in the annual winter solstice on Thursday, indicating the coldest season of the year.

Consisting of an orbiter, a lander and a rover, the Tianwen-1 probe landed on Mars May 15, 2021, and a week later the Mars rover Zhurong, which resembles a butterfly and means "the god of fire" in Chinese mythology, drove down from its landing platform onto the Martian surface. 

Thanks to the inclination of Mars' rotation axis of 25.19 degrees, similar to that of Earth, orbiting around the sun gives the red planet distinct seasons just like Earth.

The winter solstice occurs on Mars when its sun's direct point occurs at the southernmost point, and the winter solstice fell on July 21 this year.

Wang Kechao, director of Science Popularization, the Purple Hills Observatory, the Chinese Academy of Sciences, told China Media Group (CMG) that "during one orbital cycle, the direct point of the sun also moves back and forth between 25.19 degrees north and south latitude."

"When the direct point of the sunlight is at the southernmost point, that is, 25.19 degrees south latitude, there comes the winter solstice of Mars."

01:00

Mars vs. Earth: Day, season, temperature

Different from Earth, Mars has an orbital period of about 687 Earth days, which means one Martian year is equivalent to about 1.9 Earth years, and its last winter solstice started on September 2, 2020.

Due to a different orbit, the length of each season on Mars is also different from that of Earth.

"Each of its seasons is longer than that of Earth, and the eccentricity of the Mars' revolution orbit is relatively large, which leads to Mars' fast and short pass through the perihelion. While it takes a relatively long time for Mars to pass through the aphelion," said Wang.

"In the winter season, Mars is located near the perihelion. Therefore, in the northern hemisphere of Mars, the spring and summer seasons are about one-third longer than the autumn and winter seasons."

Moreover, the temperature in winter on Mars is significantly lower than that on Earth, as Mars receives less solar radiation due to its distance from the sun.

"Each season on Mars is colder than that on Earth. For example, in the current winter, the temperature in the northern hemisphere of Mars can reach as low as minus 100 degrees, which is colder than anywhere on Earth," Wang added.

Martian landscape image. /CNSA

Martian landscape image. /CNSA

Protection against weather

To tackle the frequent sandstorms in the winter, engineers have designed four tailored measures, including low temperature resistance, sand resistance, power security and other aspects, in the shaping of the Zhurong rover to ensure the safe operation of the Mars patrol and exploration process.

"The first is that the battery pieces installed in the solar wings are made of a special material called superhydrophobic material," said Peng Song, deputy director designer of the Tianwen-1 probe. "Just as how a lotus leaf can let the water drops slip, such material makes it easier for the dust to be blown off." 

Zhurong's solar wings are also equipped with directional sun-tracking capability which enables the rover's wings to shift as the sun rises, like those of a sunflower, to maximize solar energy absorption despite the low angle of the sun during the winter. 

The third measure is that the rover can conserve energy and reduce energy consumption by changing its working patterns in windy and sandy weather.

If all of the first three measures fail to solve the energy problem, the rover will go into dormancy until the dust clears, when it will wake up automatically and resume work, according to Peng.

As of May 15, 2022, China's first Mars mission, Tianwen-1, has been smoothly going on for a whole year. /CGTN graphic designed by Yin Yating

As of May 15, 2022, China's first Mars mission, Tianwen-1, has been smoothly going on for a whole year. /CGTN graphic designed by Yin Yating

China's Mars Mission

May 15, 2022, marks the first anniversary of the remarkable touchdown by China's Tianwen-1 on Mars in the southern part of Utopia Planitia, a vast plain on the northern hemisphere of the red planet, symbolizing the country's first probe landing on a planet other than Earth.

The name Tianwen, which means "Questions to Heaven," comes from ancient Chinese poet Qu Yuan's masterpiece and reflects China's persistence in seeking truth and exploring the universe.

The China National Space Administration (CNSA) released the first photographs taken by Zhurong last June 11, solidifying the success of the country's first Mars exploration mission.

Upon landing, Zhurong has kept moving southward and transmitted data back to Earth.

In addition to exploring the Mars surface, it also passed through multiple complex terrains and detected Martian rocks, sand dunes and impact craters, thus obtaining a large amount of data.

By August 15 last year, the Mars rover had worked on the red planet for 90 Martian days, or about 92 days on Earth, accomplishing all scheduled tasks. Since it was in good condition, the rover continued service despite reaching its 90-day target.

Zhurong also performed an in-orbit relay communication test last November with the European Space Agency's Mars Express spacecraft.

Read More:

Beyond Infinity: One year on Tianwen-1's triumphant landing on Mars

How does China's Mars rover cope with winter on the Red Planet?

Fri, 22 Jul 2022 19:11:00 -0500 en text/html https://news.cgtn.com/news/2022-07-23/Expert-How-will-China-s-Zhurong-rover-survive-Mars-coldest-season--1bTNpWlARTG/index.html
Killexams : Mapping the journey to federal IT transformation

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may Boost our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may Boost our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may Boost our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Sat, 30 Jul 2022 12:05:00 -0500 en text/html https://www.nextgov.com/sponsors/2022/07/mapping-journey-federal-it-transformation/375144/
Killexams : Here's Everything We Know About The White Lotus Season 2

Everything to Know About 'White Lotus' Season 2

HBO Max

The freshman season of HBO's The White Lotus was met with rave reviews from both fans and critics alike, landing the satire a whopping 20 (!) nominations at the September 12 Primetime Emmy Awards. Now, the Mike White-created series is returning for a highly anticipated second season with a whole new cast and location of Sicily, Italy, but the same ironic take on white privilege and upperclass entitlement.

Jennifer Coolidge, who is nominated for an Emmy for her performance as resort guest Tanya McQuoid, will be the only original cast member reprising her role. A newly minted, star-studded cast will be joining the fray and playing the vacationers and staffers. Read on for everything we know so far about season 2 of the hit show, White Lotus: Sicily.

RELATED: Jake Lacy Finally Gets to Play the Asshole

What Will Season 2 of The White Lotus Be About?

HBO hasn't yet released the plot, but the sophomore installment will presumably loosely follow the same premise of season 1 and feature a group of wealthy guests dropped into a luxe resort. This time, though, instead of Hawaii, the crew will be checking into a hotel in Sicily, Italy, according to Variety.

Who Is in Season 2 of The White Lotus?

The first season had a stacked cast (many of whom received Emmy nominations for their roles), including Connie Britton, Murray Bartlett, Sydney Sweeney, Coolidge, Steven Zahn, Jake Lacy, and Alexandra Daddario. While Coolidge is the only original member who will be returning, the next season will see more big names stepping into the roles of guests and staff.

According to Deadline, F. Murray Abraham, Michael Imperioli, and Adam DiMarco are playing a three-generational, grandfather-son-grandson trio named Bert Di Grasso, Dominic De Grasso, and Elbie Di Grasso. Tom Hollander will play an English man, Quentin, traveling with his friends and nephew, and Haley Lu Richardson will portray a young woman named Portia who is on a trip with her boss. Theo James and Meghann Fahy are a couple named Cameron and Daphne Babcock vacationing alongside another duo, Ethan and Harper Spiller, played by Will Sharpe and Aubrey Plaza. Leo Woodall rounds out the cast as an enthralling guest traveling alone.

Where Was Season 2 of The White Lotus Filmed?

Season 1 was filmed at a Four Seasons resort in Maui, and this season was similarly filmed on-site in Sicily, Italy.

Where Can You Watch The White Lotus?

The seven-episode arc (one more than last season) can be streamed on HBO Max.

When Will Season 2 of The White Lotus Premiere?

While an exact date has not been released, Variety confirmed that the new season will drop sometime in October 2022.

Thu, 04 Aug 2022 04:29:00 -0500 en-US text/html https://www.yahoo.com/now/heres-everything-know-white-lotus-162902359.html
Killexams : Biden administration goes to war with Republicans over $80billion IRS enforcement: White House has three ex-commissioners 'debunk lies' Americans plan will target Americans ...

Biden administration goes to war with Republicans over $80billion IRS enforcement: White House has three ex-commissioners 'debunk lies' Americans plan will target Americans earning under $400,000 - as well as mega-rich tax evaders

  • Tucked into the $433 billion reconciliation deal is $80 billion over 10 years to expand the IRS
  • According to the Congressional Budget Office the beefed-up enforcement would bring in net $127 billion over 10 years
  •  Dubbed the Inflation Reduction Act, Democrats hope to push through the bill without any Republican votes next month
  •  Democrats plan to enforce existing laws and close loopholes and set a corporate minimum tax to raise funds for the bill
  • 'They're just gonna go attack every small business person,' Sen. Rick Scott said. 'We know how the IRS treats people. You're guilty until proven innocent'

Republicans are fighting back against Democrats' plans to bolster IRS enforcement to bring in revenue to pay for their Inflation Reduction Act spending bill. 

Tucked into the $433 billion reconciliation deal reached between Democratic Leader Chuck Schumer and key moderate Democrat Sen. Joe Manchin is $80 billion  over 10 years to expand the IRS and ensure Americans are paying their fair share in taxes. 

According to the Congressional Budget Office the beefed-up enforcement would bring in net $127 billion over 10 years.  

Dubbed the Inflation Reduction Act, Democrats hope to push through the bill without any Republican votes next month.  It involves at least $260 billion in new spending over 10 years, and would also raise taxes by $326 billion over that time period, according to an analysis from the nonpartisan Joint Committee on Taxation. 

The deal, which would include $433 billion in government spending on climate and health programs, would finally give President Biden and Democrats a major policy win ahead of the midterm elections.

Democrats plan to enforce existing laws and close loopholes and set a corporate minimum tax to raise funds for the bill. Republicans, however, are sounding the alarm on giving more funding to the IRS. 

'They're just gonna go attack every small business person,' Sen. Rick Scott, R-Fla., said, according to the Huffington Post. 'We know how the IRS treats people. You're guilty until proven innocent.' 

'In this bill, there is legislation to hire 86,000 more IRS agents – to supersize, put the IRS on steroids. Do the math, it's a million dollars per IRS agent,' Sen. John Barrasso, R-Wyo., said in a press conference on Wednesday. 

'You don't need that many IRS agents to go after a few people that they say are very, very rich. This is coming after the families, and the farmers, and the small businesses of America,' he warned. 

'They're just gonna go attack every small business person,' Sen. Rick Scott, R-Fla., said, according to the Huffington Post. 'We know how the IRS treats people. You're guilty until proven innocent'

Sen. Mike Crapo, ranking member on the Senate Banking Committee, said in a press release this week that it was a 'myth' that the additional funding would allow the IRS to crack down on wealthy tax cheats and corporations not paying their fair share

Sen. John Thune, R-S.D., member of the Senate Banking Subcommittee, said that too much funding was going toward enforcement and not enough toward customer service. 

'This is an agency that only succeeded in answering about one out of every 50 phone calls during the 2021 tax season,' Thune said on the Senate floor. 'Yet four percent of the $80 billion is going to taxpayer services — 57 percent goes to enforcement, so that the IRS can spend more time harassing taxpayers around this country.' 

“All of this money going to the IRS, you would think it would go towards technology first and taxpayer service second, which are related,' Sen. Rob Portman, a member of the Senate Banking Subcommittee, said at a GOP press conference Thursday.

'What it’s doing is doubling the size of the IRS in terms of people who will it be auditing,' he said. 'That’s going to affect small businesses, farmers, ranchers, and so on.'

Sen. Mike Crapo, ranking member on the Senate Banking Subcommittee, said in a press release this week that it was a 'myth' that the additional funding would allow the IRS to crack down on wealthy tax cheats and corporations not paying their fair share. 

'The brunt of any new revenue from hiring an army of IRS auditors will overwhelming hit low- and middle-income earners, people already struggling with high gas prices and 9.1 percent inflation,' he said.

Citing a report from the Joint Committee on Taxation, he argued that much of the 'tax gap' is made up of misreported trade or business activities (Schedule C items) or other income-producing activities (Schedule E items). Those who make under $100,000 are most likely to underreport Schedule C or E items. 

The Treasury Department has asserted the opposite - that the vast majority of unreported income comes from those making over $100,000.  

'Referring to all tax gap and misreporting numbers as arising from 'tax cheats' is misdirection, as significant amounts arise from hard-working taxpayers simply struggling to comply with an overly complex tax code, which will become even more complex if the latest tax-and-spend bill becomes law,' Crapo said.  

Marc Goldwein, an economist with the Committee for a Responsible Federal Budget, argued that enhancing enforcement has historically been a bipartisan priority. 

'Every single president from Ronald Reagan to Donald Trump has supported more IRS funding to close the tax gap,' Goldwein said.  

The White House touted a statement from three ex-IRS commissioners endorsing the provisions and 'Debunk Lies About Increased Enforcement Affecting Anyone but Rich Tax Cheats': 

 'As former IRS commissioners, we have watched the agency closely over the years, and understand far too well that the status quo is not tenable: The IRS has a workforce that has shrunk to 1970s levels with technological infrastructure that is decades out-of-date and an audit rate that has dropped by 50 percent. The sustained, multi-year funding contained in the reconciliation package is critical to help the agency rebuild.'

'This bill is about getting to the heart of the problem' write Fred Goldberg, Charles Rossotti and John Koskinen, 'and pursuing high-end taxpayers and corporations who today illegally evade their tax obligations.' 

The IRS has a workforce that has shrunk to 1970s levels with technological infrastructure that is decades out-of-date and an audit rate that has dropped by 50 percent. 

Republicans have said that the bill would actually increase historically high inflation, and flies in the face of President Biden's promise not to raise taxes on anyone making less than $400,000. 

Central to the bill's tax provisions is a 15 percent corporate minimum tax on the 200 or so businesses that bring in over $1 billion per year, which is projected to raise $313 in revenue over 10 years. 

Republicans have predicted the increase will be passed onto workers who will make less or consumers who will pay more, not shareholders.  

The Joint Committee on Taxation found that low- and middle-income households could pay an additional $16.7 billion in taxes next year as a result of the bill. 

But the White House has noted that that estimate does not factor in increased benefits and tax credits for these households. 

'Once you account for the spending side and the other taxes that are left out -- and that includes the household consumer tax credits for various energy things, lower drug prices and health-care subsidies -- the middle class is going to be distributionally ahead,' said Goldwein, according to Bloomberg Tax. 

Advertisement
Thu, 04 Aug 2022 06:10:00 -0500 text/html https://www.dailymail.co.uk/news/article-11081417/Biden-administration-goes-war-Republicans-80billion-IRS-enforcement.html
Killexams : Acquisition of agricultural land in Charsadda for dumping site stayed

PESHAWAR: The Peshawar High Court on Wednesday issued a stay order temporarily stopping the Charsadda district administration from acquiring an agricultural land, mostly producing lotus root, to set up a dumping ground for waste.

A bench consisting of Justice Syed Arshad Ali and Justice Dr Khursheed Iqbal issued notice to Charsadda’s deputy commissioner seeking his response to a petition filed by a landlord, Mohammad Hashim Khan, against the invoking of Section 4 of the Land Acquisition Act by the administration for acquiring his land in Charsadda city and converting it into a dumping site.

The petitioner requested the court to declare illegal a notification issued by the administration under Section 4 of the Land Acquisition Act for being a health and environmental issue in Majoki area, Charsadda, as well as adjoining areas.

He requested the court to declare the establishment of the dumping ground in Majoki area in violation of the Constitution and the provincial, federal and international environmental protection laws and standards.

High court seeks Charsadda admin’s reply to petition

The petitioner also highlighted the archaeological significance of lotus root for Charsadda district and sought the court’s orders for the government to hold regular research on its cultivation as well as help growers in that respect.

His lawyer, Ali Gohar Durrani, said lotus flower was a symbol of enlightenment and rebirth in Gandhara civilisation, while Charsadda was known as Pushkulavati (City of Lotus) in ancient times.

He said lotus root locally called nadru or barsanday was eaten as vegetable but The lawyer said the cultivation of lotus root dwindled and was confined to only three places, including Pajjagi area in Peshawar and Majoki and Turangzai areas in Charsadda.

He said a petition was recently filed with the high court, wherein the graveyard in Charsadda having been used as a dumping ground came into surface.

The counsel added that the court had issued orders in that case for the establishment of a proper dumping site.

He said the court had ordered the identification of site for the dumping site, while a committee was also constituted for the purpose.

Mr Durrani said a meeting was held on the matter and directions were issued to invoke Section 4 of the Land Acquisition Act.

He said a survey was conducted and of all the places, the petitioner’s property, which was known for the cultivation of lotus root, had been chosen by the administration as the dumping site.

The lawyer argued that the local administration didn’t realise that it was an agricultural area, which was good for growing crops and if it was made a dumping site, it should have serious issues for environment, groundwater and the people’s health.

He contended that the notification was issued in haste ‘in the garb of the orders of the high court’.

Mr Durrani said a report of the sub-engineer of the tehsil municipal officer’s office declared that the site was located in the vicinity of a residential area and was waterlogged, so it was good for growing lotus root.

Published in Dawn, July 28th, 2022

Wed, 27 Jul 2022 15:06:00 -0500 en text/html https://www.dawn.com/news/1701880
Killexams : National DICE Data Center Management, Operations and Cooling Summit

What You'll Learn

  • Power and cooling is one the largest, critical segments of the data center industry, what innovations are taking place that are making operations run more efficiently?
  • How will Northern Virginia navigate power limitations?
  • Air cooling, liquid cooling, or other? Which technique is best when considering cost and scale?
  • Sustainability is becoming an increasing priority, but how do we ensure we're on the right path to getting there?
  • Is Los Angeles and Northern California leading the charge on sustainable operations? What best practices can be shared?
  • Is the current infrastructure ready for new technologies? How do we brace for the future?
  • With increasing population growth across major markets like Dallas and Denver, how are operators planning for more density? 
  • What are the impacts on uptime availability, resiliency, sustainability, and power costs of ever-higher power densities and cooling requirements?

How You'll Do More Business: Dive into power, cooling, density, DCIM trends that are currently being adopted by industry experts, and how to optimize your data center for the most optimal performance. With rack densities increasing and capacity continuing to hit limitations, maximizing what you have currently and running it efficiently will be a key differentiating factor. 

Who You’ll Meet: Owners, providers, engineers, brokers, contractors, director of operations, director of operations, CIOs, investors, lawyers, CEOs, vice president of design and construction

For questions, or interest in becoming a speaker or sponsor, please email our DICE Global Director, Adam Knobloch, adam.knobloch@bisnow.com

Wed, 03 Aug 2022 11:02:00 -0500 en text/html https://www.bisnow.com/events/san-jose/data-center/national-dice-data-center-management-operations-and-cooling-summit-7417
Killexams : Honduras: International mission will observe "Fraude sobre el Gualcarque" case

25 July 2022 - The oral hearings begin today in the corruption trial in the concession of the Gualcarque River, in Honduras. The International Federation for Human Rights (FIDH) and other organisations that make up the Qualified Observation Mission in the Berta Cáceres case in Honduras will follow the oral hearings.

The Observation Mission hopes and calls for a transparent and public process in the trial of the "Fraud in the Gualcarque" case. This trial seeks accountability for those involved in the network of corruption that allowed for fraudulent concessions of the Gaulcarque River. These concessions are still in force in the territories of the Lenca community, violating their rights to land and water. The complaint is linked to the 2016 murder of renowned environmental and human rights defender Berta Cáceres.

This trial is also emblematic because it is the first time in the country that Indigenous communities — direct victims of these criminal acts — have become parties to a corruption case for violation of their human rights. The Council of Popular Indigenous Organisations (COPINH) appealed to be included as victims in the process while some organisations of this Mission, including the International Federation for Human Rights (FIDH), the Centro de Investigación y Promoción de los Derechos Humanos (CIPRODEH), the Centro para la Acción Legal en Derechos Humanos (CALDH), and Colectivo de Abogados José Alvear Restrepo (CAJAR), sent letters of support (amicus curiae). This led the Supreme Court of Justice of Honduras to grant COPINH, and later the Indigenous Council of Rio Blanco, the right to be considered parties to the trial and exercise their rights therein.

The trial of six people for the crimes of fraud, abuse of authority, falsification of public documents, and use of false documents in the concession of the Agua Zarca Project begins 25 July 2022. Among them are former public officials and the former manager of the company Desarrollos Energéticos S.A. (DESA), David Castillo, who was recently sentenced to 22 and a half years in prison as co-author of the murder of Berta Cáceres.

The Observation Mission also calls on the national and international community, in particular the diplomatic missions in Tegucigalpa, to closely observe and follow this trial given its importance for human rights jurisprudence, the rights of Indigenous peoples, and the fight against corruption.

The Observation Mission was formed in September 2018 to observe the first trial regarding the murder of Berta Cáceres, a representative of COPINH and defender of human rights, land, and the environment. Since then, the Mission has observed and expressed its opinion on two trials. The Mission will continue to demand justice for all acts and actors responsible for her assassination.

Sun, 24 Jul 2022 12:00:00 -0500 en text/html https://www.fidh.org/en/region/americas/honduras/international-mission-will-observe-fraud-in-the-gualcarque-case
Killexams : Atlanta-Based Lotus Moon Skin Care Celebrates 20 Years with Symbol of Peace

ATLANTA, Aug. 2, 2022 /PRNewswire/ -- In celebration of their 20th anniversary, Lotus Moon Skin Care created a limited edition, commemorative "Peace Begins With Me," candle. As founder and CEO, Lake Louise sends a message, "With all of the turmoil and fighting going on in the world, we wanted to create something that would encourage us to turn inward and reflect on how we can create more peace within ourselves so that we may shine it on others."

In celebration of their 20th anniversary, Lotus Moon Skin Care created a limited edition, commemorative "Peace Begins With Me," candle. 100% coconut-based wax, blended with essential oils of lavender, geranium, and ylang ylang, designed to relax the body mentally and emotionally. It includes crushed rose petals, a symbol of love, and topped with a citrine crystal, which is associated with positivity and optimism.

This commemorative candle uses 100% coconut-based wax, blended with essential oils of lavender, geranium, and ylang ylang, designed to relax the body mentally and emotionally. It includes crushed rose petals, a symbol of love, and topped with a citrine crystal, which is associated with positivity and optimism.

Entrepreneur Louise founded Lotus Moon Skin Care in Oakland, CA, in 2002. As a lifelong learner and former educator with a master's degree in education from Stanford University, she states, "I ‛dug my heels' into ingredients and wellness research to launch Lotus Moon Skin Care."

Lake says she was the first ecommerce brand in the clean beauty space. In 2002 there were no website design plug n play apps, so she enrolled in an HTML course at the local junior college to learn how to code her own website from scratch.

"Brick by brick" her business grew, and subsequently they moved to their current location in Atlanta, GA, in 2014. From day one, sustainable business practices have always been a part of what the team at Lotus Moon Skin Care focuses on. Consideration of the impact on the environment is woven into their business culture.

The premiere product, Skin Regen, a scar-fading oil, was actually created for Lake's mother to help her heal a post-surgical scar. It was the start of the brand's vision of wanting a cleaner alternative to petroleum to help heal the skin after an injury or surgery.

Their key to progressing forward is in giving back. Lotus Moon Skin Care is on a mission to support social and economic justice organizations through their 1% donation program. Also, they have a mission-driven hiring practice that seeks to employ formerly incarcerated and other marginalized people. Products are plant-based and cruelty-free. In addition, manufacturing, bottling, and filling takes place in the U.S.A.

Looking back over the past 20 years, Lake recounts, "Little did I know, what started as a single product to address my own hormone-related skin changes would turn into skincare solutions for 1,000's of women who experience the same."

CONTACT:
Michelle Stewart
7709320018
341727@email4pr.com

Looking back over the past 20 years, Lake recounts, "Little did I know, what started as a single product to address my own hormone-related skin changes would turn into skincare solutions for 1,000's of women who experience the same."

Cision

View original content to get multimedia:https://www.prnewswire.com/news-releases/atlanta-based-lotus-moon-skin-care-celebrates-20-years-with-symbol-of-peace-301597545.html

SOURCE Lotus Moon Skin Care

Tue, 02 Aug 2022 00:45:00 -0500 en-CA text/html https://ca.finance.yahoo.com/news/atlanta-based-lotus-moon-skin-124200725.html
Killexams : Alvotech Expands its Board of Directors as part of Transition from Private to Publicly Traded Company

Alvotech

  • Four new members enhance independence and diversity of Board of Directors

  • Alvotech is dual listed on NASDAQ in the U.S. and NASDAQ First North Growth Market in Iceland under the symbol “ALVO”

REYKJAVIK, Iceland, July 14, 2022 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, today announced the expansion of its board of directors as part of its transition from a private to a publicly traded company. The four incoming board members, Lisa Graver, Arni Hardarson, Linda McGoldrick and Ann Merchant joined Robert Wessman, founder and Executive Chairman, Richard Davies, Tomas Ekman and Faysal Kalmoua. Ms. Merchant, Ms. McGoldrick, and Mr. Davies serve as independent directors of the board.

“I am delighted to welcome our new members of our board at a crucial time in our evolution,” said Robert Wessman, Executive Chairman and founder of Alvotech. “The scientific expertise, operational experience, and capital markets acumen of the new board members will be important in supporting our mission to enhance the sustainability of the global healthcare system by expanding access to biologic medicines.”

Robert Wessman founded Alvotech in 2013 and has served as Chairman of the Board of Directors since 2019. He is also Chairman of the board of directors of Alvogen and Lotus Pharmaceuticals and serves as a board member at Fuji Pharma Co. Ltd. Prior to founding Alvotech, Mr. Wessman as CEO led Actavis, a small domestic pharmaceutical company, into a global generics company. He then founded Alvogen, transforming it from a CMO into a global generics company and has served as Alvogen’s CEO and Chairman. Mr. Wessman is also a partner in the Aztiq Group (“Aztiq”). He has a BS degree in Business Administration from the University of Iceland.

Richard Davies currently serves as Deputy Chairman of the Board of Directors for Alvotech and Chairman of the Remuneration Committee. He also currently serves as CEO of Auregen Bio Therapeutics, and previously served as CEO of Bonesupport, Senior VP and CCO of Hospira and in various leadership roles at Amgen. Mr. Davies holds a BS degree in applied chemistry from the University of Portsmouth and an MBA from the University of Warwick.

Linda McGoldrick serves as Chairman of Alvotech’s Board of Directors’ Audit Committee. She has served in numerous management and non-executive director roles in the healthcare and life sciences industries, internationally. These include leadership positions at Marsh-MMC Companies, Veos, Kaiser Permanente International, Compass Pathways and Zillion. She founded and currently serves as Chairman and CEO of Financial Health Associates International and is the CEO of 2EnableHealth. In 2012, Ms. McGoldrick was named as one of the Top 100 Corporate Directors in Remuneration of Fortune 100 Companies by the Financial Times. She received an MSW in Healthcare from the University of Pennsylvania and an MBA from The Wharton School.

Thomas Ekman has served as one of Alvotech’s directors since 2019. He is a partner at CVC Capital Partners and a member of CVC’s Nordics team. Previously Mr. Ekman was partner and MD at 3i Group. He holds Master of Science degrees from the University of Strathclyde and Chalmers University of Technology and an MBA from IMD in Switzerland.

Lisa Graver has served in various leadership positions at Alvogen since June 2010, including as CEO of Alvogen U.S. since August 2015. Prior to joining Alvogen, Ms. Graver was VP of Intellectual Property and Senior Director of Intellectual Property at Actavis. She holds a BS degree in biology from Lakehead University and a Juris Doctor degree from Case Western University School of Law.

Arni Hardarson is a partner in Aztiq and served as General Counsel and Deputy CEO of Alvogen and been part of Alvogen’s executive team since 2009. Prior to joining Aztiq and Alvogen, Mr. Hardarson was VP of Tax and Structure at Actavis, and served as head of tax and legal services at Deloitte. He holds a master’s degree in law from the University of Iceland.

Faysal Kalmoua has served as one of Alvotech’s directors since 2020 and is a partner in Aztiq. Previously, Mr. Kalmoua held various management positions at Alvogen Iceland ehf. and Alvogen Inc, and for Synthon. He holds a Master of Chemistry degree from Radboud University Nijmegen and an executive MBA from Insead.

Ann Merchant has served as VP for MorphoSys since 2018 and Head of Global Supply Chain since January 2019. Prior to joining MorphoSys, Ms. Merchant served as President of Schreiner Medpharm and held various roles at Amgen, including VP Head of International Supply Chain. She holds an MBA from Henley Business School and a BS degree in languages from Georgetown University.

Alvotech’s shares were listed on the Nasdaq stock exchange in New York on June 16, 2022. Following the debut of Alvotech as a publicly traded company, the largest Icelandic company to make its debut on a U.S. stock exchange, Alvotech was also listed on the Nasdaq First North Growth Market in Iceland on June 23, 2022, thus becoming the first dual-listed Icelandic company on both a United States and Icelandic stock exchange.

About Alvotech

Alvotech specializes in making biosimilars, to Boost lives by expanding access to affordable biologic medicines. Founded by Robert Wessman, Alvotech seeks to be a global leader in the biosimilar space by delivering high-quality, cost-effective biologics, enabled by a vertically integrated approach from R&D to fill and finish manufacturing. To enable global reach, Alvotech has formed a network of strategic commercial partnerships in over 90 countries, including the United States, Canada, Europe, Asia, Latin America, Africa and the Middle East. Alvotech’s current portfolio of eight biosimilars and biosimilar candidates, includes AVT02, a biosimilar to Humira® which is approved and marketed in Europe (Hukyndra®) and Canada (Simlandi®) and seven biosimilar candidates targeting immunology, oncology, respiratory, bone disease and ophthalmology. For more information, please visit www.alvotech.com. None of the information on the Alvotech website shall be deemed part of this press release.

Forward-Looking Statements

Certain statements in this communication may be considered “forward-looking statements.” Forward-looking statements generally relate to future events or the future financial operating performance of Alvotech. For example, Alvotech’s expectations regarding capitalization through equity or debt, future growth, results of operations, performance, future capital and other expenditures including the development of critical infrastructure for the global healthcare markets, competitive advantages, business prospects and opportunities including pipeline product development, future plans and intentions, results, level of activities, performance, goals or achievements or other future events, the timing of the announcement of clinical trial results, the ability to obtain regulatory or maintain regulatory approvals for Alvotech’s products and product candidates, the timing of the announcement of clinical trial results, regulatory approvals and market launches, and the estimated size of the total addressable market of Alvotech’s pipeline products. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expect”, “intend”, “will”, “estimate”, “anticipate”, “believe”, “predict”, “potential” or “continue”, or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Alvotech and its management, are inherently uncertain and are inherently subject to risks, variability, and contingencies, many of which are beyond Alvotech’s control. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) the outcome of any legal proceedings that may be instituted against Alvotech or others following the business combination between Alvotech Holdings S.A., Oaktree Acquisition Corp. II and Alvotech, with Alvotech as the surviving company (the “Business Combination”); (2) the ability to meet or maintain stock exchange listing standards; (3) the risk that the Business Combination disrupts current plans and operations of Alvotech; (4) the ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition, the ability of the Alvotech to grow and manage growth profitably, maintain key relationships and retain its management and key employees; (5) changes in applicable laws or regulations; (6) the possibility that Alvotech may be adversely affected by other economic, business, and/or competitive factors; (7) Alvotech’s estimates of expenses and profitability; (8) Alvotech’s ability to develop, manufacture and commercialize the product candidates in its pipeline; (9) actions of regulatory authorities, which may affect the initiation, timing and progress of clinical trials or future regulatory approvals or marketing authorizations; (10) Alvotech’s ability to obtain and maintain regulatory approval or authorizations of its product candidates, including the timing or likelihood of expansion into additional markets or geographies; (11) the success of Alvotech’s current and future collaborations, joint ventures, partnerships or licensing arrangements; (12) Alvotech’s ability, and that of its commercial partners, to execute their commercialization strategy for approved products; (13) Alvotech’s ability to manufacture sufficient commercial supply of its approved products; (14) the outcome of ongoing and future litigation regarding Alvotech’s products and product candidates; (15) the potential impact of the ongoing COVID-19 pandemic on the FDA’s review timelines, including its ability to complete timely inspection of manufacturing sites; and (16) other risks and uncertainties set forth in the section entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in Alvotech’s Registration Statement on Form F-4 or in other documents filed with the SEC. There may be additional risks that Alvotech does not presently know or that Alvotech currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. Nothing in this communication should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Alvotech does not undertake any duty to update these forward-looking statements or to inform the recipient of any matters of which any of them becomes aware of which may affect any matter referred to in this communication. Alvotech disclaims any and all liability for any loss or damage (whether foreseeable or not) suffered or incurred by any person or entity as a result of anything contained or omitted from this communication and such liability is expressly disclaimed. The recipient agrees that it shall not seek to sue or otherwise hold Alvotech or any of its directors, officers, employees, affiliates, agents, advisors, or representatives liable in any respect for the provision of this communication, the information contained in this communication, or the omission of any information from this communication.

Important Notice

Two categories of shares are listed on Nasdaq First North: (i) Alvotech shares that will also be tradable on the Nasdaq Stock Market LLC will appear on custody accounts as foreign securities marked "ALVOUS" in USD; and (ii) Alvotech shares that will be tradable only on Nasdaq First North will appear on custody accounts marked "ALVOIS" in ISK. This second category of shares tradable on Nasdaq First North has not been, and may not be, registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”). The shares were offered only to non-U.S. Persons outside the United States in transactions exempt from the registration requirements of the Securities Act in reliance on Regulation S. By acquiring these shares, the holder represented and warranted that it (a) is not a U.S. Person (as defined in Regulation S) and (b) is not holding the shares for the account or benefit of any U.S. Person. Such shares are “restricted securities” as defined under Rule 144(a)(3) promulgated under the Securities Act, and may not be taken up, offered, sold, resold, delivered or distributed, directly or indirectly within, into or from the United States or to, or for the account or benefit of, U.S. Persons except: (a)(i) in an offshore transaction meeting the requirement of Regulation S, (ii) pursuant to an available exemption from the registration requirements of the Securities Act, or (iii) pursuant to an effective registration statement under the Securities Act. Resales or reoffers of shares made offshore in reliance on Regulation S may not be sold to, or for the account or benefit of, any U.S. Person (as defined in Regulation S) during the distribution compliance period under Regulation S.

CONTACTS

Alvotech Investor Relations
alvotech.ir@alvotech.com

Alvotech Corporate Communications
alvotech.media@alvotech.com

Thu, 14 Jul 2022 00:13:00 -0500 en-US text/html https://finance.yahoo.com/news/alvotech-expands-board-directors-part-120000529.html
Killexams : Jennifer Coolidge says iconic film role helped her have sex with ‘200 people’

Jennifer Coolidge. (GC Images)

Jennifer Coolidge has played her fair share of memorable roles, but it seems one in particular has taken the horny biscuit. 

In an interview with Variety, the Legally Blonde actor revealed that her time playing Stifler’s mom in the 1999 sexy comedy American Pie really upped her body count.

In the film – and subsequent sequels – Coolidge cameos as Jeanine Stifler and has a fling with her son’s classmate Paul Finch, while leaving all his friends speechless with her sexual allure. 

The cameo immediately dubbed her as a MILF among a generation – a title Coolidge has accepted proudly. 

Ya know, I got a lot of play being a MILF,” she explained, “And I got a lot of sexual action from American Pie. There was so many benefits to doing that movie.

Jennifer Coolidge as Jeanine in American Pie.
Jennifer Coolidge as Stifler’s mom in American Pie. (YouTube)

It was then that she revealed that “there would be, like, 200 people that I would never have slept with”, had it not been for that film.

From the highs of American Pie, charming 200 people was not the only benefit for Coolidge as her career unfolded in front of her. 

Schitt’s Creek actor Eugene Levy noticed the sheer popularity of Coolidge after her sexually-charged performance and recommended her for Christopher Guest’s 2000 mockumentary  Best in Show. 

“She can really jump by leaps and bounds from take to take,” Levy told Variety, “there’s not that many people that have the ability to do that.”

Since her days scooping up iconic role after iconic role, Jennifer Coolidge has now made a comeback into the world of TV. 

She stars as socialite Tanya McQuoid in the HBO drama The White Lotus, which has taken gay twitter by storm for not only involving Coolidge, but also for its iconic rimming scene between actors Lukas Gage and Eric Dane

Coolidge has also finally received a well-deserved Emmy nomination for best supporting actress in a limited or anthology series. 

The series follows the the dramatic goings-on between the staff and guests at a luxury hotel with the second season filmed on the coast of Sicily and set to air in October.

Wed, 03 Aug 2022 23:25:00 -0500 en-GB text/html https://www.pinknews.co.uk/2022/08/04/jennifer-coolidge-american-pie-stiflers-mom-sex/
190-956 exam dump and training guide direct download
Training Exams List